Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium

P Pyatilova, C Akin, I Alvarez-Twose, M Arock, P Bonadonna, K Brockow, JH Butterfield, S Broesby-Olsen, MC Carter, M Castells, TI George, J Gotlib, G Greiner, T Gulen, K Hartmann, O Hermine, HP Horny, M Jawhar, M Lange, JJ LyonsM Maurer, DD Metcalfe, B Nedoszytko, M Niedoszytko, A Orfao, A Reiter, J Schwaab, Karl Sotlar (Co-author), WR Sperr, M Triggiani, P Valent, F Siebenhaar

Research output: Contribution to journalReview articlepeer-review

9 Citations (Web of Science)
Original languageEnglish
Pages (from-to)2015-2024
JournalJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
Volume10
Issue number8
DOIs
Publication statusPublished - 2022

Keywords

  • KIT D816V MUTATION
  • QUALITY-OF-LIFE
  • ELEVATED SERUM TRYPTASE
  • MAST-CELL DISORDERS
  • DIAGNOSTIC-CRITERIA
  • HIGH PREVALENCE
  • ALLELE BURDEN
  • ANAPHYLAXIS
  • RISK
  • CLASSIFICATION

Cite this